Reset Map3 Results
524 N. Boonville Springfield, , MO , 65806 United StatesThe Center for Biomedical and Life Sciences (CBLS) at Missouri State University is committed to the development and support of advanced biotechnology industries, utilizing knowledge gained in our research to improve human health. Target areas of interest include: Neurological pathology and treatment Bioactivity of natural products Drug discovery Pathological microbiology Chemical testing and analysis Our focus lies in understanding the cellular and molecular mechanisms involved in neuron-glia interactions that promote and sustain chronic peripheral and central sensitization. A primary goal of our research is to determine the signaling pathways by which inflammatory and anti-inflammatory agents control neuropeptide gene expression in disorders involving the trigeminal nerve. Currently, we are studying the regulation of the neuropeptide calcitonin gene-related peptide gene (CGRP) expression in cultured and trigeminal neurons, neuronal-like cell lines, in vivo animal models, and clinical studies. Another major focus of our research has been to elucidate the cellular/molecular mechanisms mediated by anti-migraine drugs and inflammatory stimuli that activate MAP kinase pathways in neurons and glial cells within the trigeminal ganglion and spinal trigeminal nucleus. In addition, we have begun to study the effects of nutraceutical compounds on neuronal-glial cell interactions within the ganglion and spinal trigeminal nucleus under normal and inflammatory conditions. We have also initiated studies to identify novel biological compounds that inhibit inflammatory pathways and regulate miRNA expression, and have been investigating the mechanism of action of a novel drug to treat epilepsy using primary hippocampal cultures and in vivo models. More recently, we have also begun to use denatured gradient gel electrophoresis (DGGE) to study changes in the bacteria resideing the the digestive system in repsonse to prolonged inflammatory conditions (acute to chronic pain) and alterations in diet.
524 N. Boonville Springfield, , MO, 65806 United StatesThe Center for Biomedical and Life Sciences (CBLS) at Missouri State University is committed to the development and support of advanced biotechnology industries, utilizing knowledge gained in our research to improve human health. Target areas of interest include: Neurological pathology and treatment Bioactivity of natural products Drug discovery Pathological microbiology Chemical testing and analysis Our focus lies in understanding the cellular and molecular mechanisms involved in neuron-glia interactions that promote and sustain chronic peripheral and central sensitization. A primary goal of our research is to determine the signaling pathways by which inflammatory and anti-inflammatory agents control neuropeptide gene expression in disorders involving the trigeminal nerve. Currently, we are studying the regulation of the neuropeptide calcitonin gene-related peptide gene (CGRP) expression in cultured and trigeminal neurons, neuronal-like cell lines, in vivo animal models, and clinical studies. Another major focus of our research has been to elucidate the cellular/molecular mechanisms mediated by anti-migraine drugs and inflammatory stimuli that activate MAP kinase pathways in neurons and glial cells within the trigeminal ganglion and spinal trigeminal nucleus. In addition, we have begun to study the effects of nutraceutical compounds on neuronal-glial cell interactions within the ganglion and spinal trigeminal nucleus under normal and inflammatory conditions. We have also initiated studies to identify novel biological compounds that inhibit inflammatory pathways and regulate miRNA expression, and have been investigating the mechanism of action of a novel drug to treat epilepsy using primary hippocampal cultures and in vivo models. More recently, we have also begun to use denatured gradient gel electrophoresis (DGGE) to study changes in the bacteria resideing the the digestive system in repsonse to prolonged inflammatory conditions (acute to chronic pain) and alterations in diet.
524 N. Boonville Springfield, MO 65806The Center for Biomedical and Life Sciences (CBLS) at Missouri State University is committed to the development and support of advanced biotechnology industries, utilizing knowledge gained in our research to improve human health. Target areas of interest include: Neurological pathology and treatment Bioactivity of natural products Drug discovery Pathological microbiology Chemical testing and analysis Our focus lies in understanding the cellular and molecular mechanisms involved in neuron-glia interactions that promote and sustain chronic peripheral and central sensitization. A primary goal of our research is to determine the signaling pathways by which inflammatory and anti-inflammatory agents control neuropeptide gene expression in disorders involving the trigeminal nerve. Currently, we are studying the regulation of the neuropeptide calcitonin gene-related peptide gene (CGRP) expression in cultured and trigeminal neurons, neuronal-like cell lines, in vivo animal models, and clinical studies. Another major focus of our research has been to elucidate the cellular/molecular mechanisms mediated by anti-migraine drugs and inflammatory stimuli that activate MAP kinase pathways in neurons and glial cells within the trigeminal ganglion and spinal trigeminal nucleus. In addition, we have begun to study the effects of nutraceutical compounds on neuronal-glial cell interactions within the ganglion and spinal trigeminal nucleus under normal and inflammatory conditions. We have also initiated studies to identify novel biological compounds that inhibit inflammatory pathways and regulate miRNA expression, and have been investigating the mechanism of action of a novel drug to treat epilepsy using primary hippocampal cultures and in vivo models. More recently, we have also begun to use denatured gradient gel electrophoresis (DGGE) to study changes in the bacteria resideing the the digestive system in repsonse to prolonged inflammatory conditions (acute to chronic pain) and alterations in diet.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.